The Role of Noncontrast Computed Tomography Markers in Predicting the Clinical Outcome of Cerebral Hemorrhage

The goal of this observational study is to To investigate the ability of Noncontrast Computed Tomography to predict clinical prognosis in Intracerebral Hemorrhage.

The main question it aims to answer is:How to judge the prognosis of patients with cerebral hemorrhage by CT image reading at admission.

Not Yet Recruiting

Trial opening soon.

Get Notified

Key information

Conditions

Intracerebral Hemorrhage Brain Diseases Cardiovascular Diseases Central Nervous System Diseases Cerebral Hemorrhage Cerebrovascular Disorders Hemorrhage Intracranial Hemorrhages Nervous System Diseases Pathologic Processes Pathological Conditions, Signs and Symptoms Vascular Diseases

Age range

18 year and older

Sex eligibility

All sexes

Study type

Observational

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

Age≥18 years
had completed a CT examination within 24 h of disease onset;
had a hemorrhage that was located in the brain parenchyma, including the basal ganglia, thalamus,brain lobes, brainstem, and cerebellum.

Exclusion criteria

had secondary ICH caused by brain trauma,cerebrovascular malformations, aneurysms, and tumors;
had ischemic cerebral infarction hemorrhagic transformation;
had undergone surgical treatment (e.g.hematoma removal or puncture drainage) before the CT examination;
had images of poor quality that could notbe accurately evaluated;
had a hematoma withborders that could not be delineated, thus precluding delineation of the region of interest (ROI).

Treatment and study plan

Primary outcomes

The prognosis of cerebral hemorrhage at 90 days

Time frame: 90 days

The Modified Rankin Scale was used to evaluate the prognosis of the patients, and MRS Score >2 indicated poor prognosis

Sponsors and collaborators

Lead sponsor

Jin Hu

Other

Registry information

Important dates

Study start: 2024
Primary completion: 2024
Study completion: 2024
First posted: Aug 2, 2024
Registry last updated: Aug 2, 2024

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.

Not Yet Recruiting